1|0|Public
50|$|LY-303870, or <b>lanepitant</b> (figure 5), is an N-acetylated reduced amide of L-tryptophan {{that was}} {{discovered}} by Eli Lilly. It underwent phase IIa clinical trials {{for the treatment of}} osteoarthritis pain but showed no significant effects. Eli Lilly made some SAR work on its structure and developed some compounds that did not enter clinical trials.|$|E

